Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
21.72
-0.08 (-0.37%)
Jul 10, 2026, 9:40 AM EDT - Market open
Adaptive Biotechnologies Operating Metrics
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Clonoseq Tests Delivered | 115.07K | 105.59K | 96.49K | 88.98K | 82.18K | 76.11K | 70.84K | 66.31K | ||||||||||||||
| Number of Clonoseq Tests Delivered Growth | 40.01% | 38.74% | 36.21% | 34.19% | 33.72% | 34.71% | 37.98% | 44.41% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRD | 235.71M | 212.33M | 190.60M | 171.28M | 156.62M | 145.53M | 136.14M | 123.34M | ||||||||||
| MRD Growth | 50.49% | 45.90% | 40.00% | 38.87% | 37.46% | 41.65% | 36.03% | 29.33% | ||||||||||
| Immune Medicine | 59.70M | 64.64M | 62.16M | 33.94M | 32.90M | 33.43M | 41.14M | 45.43M | ||||||||||
| Immune Medicine Growth | 81.45% | 93.38% | 51.09% | -25.29% | -45.67% | -50.50% | -48.32% | -51.79% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration | 37.68M | 41.28M | 44.78M | 14.55M | 12.36M | 13.45M | 17.87M | 22.37M | ||||||||||
| Collaboration Growth | 204.77% | 206.88% | 150.58% | -34.98% | -67.59% | -68.41% | -64.93% | -65.19% | ||||||||||
| Immune Medicine Service | 22.02M | 23.36M | 17.38M | 19.39M | 20.54M | 19.98M | 23.27M | 23.06M | ||||||||||
| Immune Medicine Service Growth | 7.21% | 16.94% | -25.31% | -15.89% | -8.37% | -19.96% | -18.79% | -23.09% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
| MRD | 31.44M | 15.19M | -1.79M | -14.87M | -28.08M | -41.22M |
| Immune | 4.24M | 9.16M | 5.36M | -23.56M | -24.52M | -26.01M |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | 211.71M | 192.83M | 174.10M | 156.28M | 144.12M | 133.03M | 123.64M | 115.84M | ||||||||||
| Service Growth | 46.89% | 44.96% | 40.81% | 34.91% | 31.69% | 29.48% | 26.06% | 24.07% | ||||||||||
| Regulatory Milestone | 24.00M | 19.50M | 16.50M | 15.00M | 12.50M | 12.50M | 12.50M | 7.50M | ||||||||||
| Regulatory Milestone Growth | 92.00% | 56.00% | 32.00% | 100.00% | 177.78% | - | 525.00% | 275.00% |